Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines

Area of Science:

• Bacteriology
• Immunology
• Vaccinology

Background:

• Whooping cough is caused by *Bordetella pertussis*.
• Acellular vaccines (ACV) are a primary prevention method, utilizing detoxified pertussis toxin (PTx) as a key component.
• Maintaining the balance between PTx detoxification for safety and preserving immunogenicity is critical for vaccine effectiveness.

Purpose of the Study:

• To review existing and potential methods for accurately measuring residual pertussis toxin (PTx) activity in acellular vaccines (ACV).
• To emphasize the importance of quality control assays for ensuring the safety and robustness of PTx detoxification procedures.
• To highlight the ongoing need for reliable assays in the development of next-generation vaccines offering longer-lasting immunity against pertussis.

Main Methods:

• Review of literature on various assays for measuring pertussis toxin (PTx) activity.
• Discussion of methods used for detoxifying PTx in acellular vaccine (ACV) production.
• Exploration of potential alternative or improved assay methodologies.

Main Results:

• Several methods exist for assessing residual PTx activity, each with specific advantages and limitations.
• Accurate measurement of PTx activity is essential for quality control in ACV manufacturing.
• The development of vaccines with longer-lasting immunity necessitates robust and reliable assay techniques.

Conclusions:

• Reliable assays are indispensable for ensuring the safety and immunogenicity of acellular pertussis vaccines (ACV).
• Continued development and validation of these assays are vital for preventing pertussis outbreaks.
• Effective quality control measures are paramount for stable and robust vaccine production.